Watchlist Price Alert

Novozymes A/S (NVZMF)

PNK: NVZMF · Real-Time Price · USD

66.70

-0.18 (-0.27%)

At close: May 14, 2025, 11:55 AM

Novozymes A/S Balance Sheet Statement

Financials in EUR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	280M	1.12B	1.04B	963M	1.18B	711M	723M	632M	812M
Short-Term Investments	4M	40M	80M	75M	119M	15M	14M	16M	4M
Long-Term Investments	38.7M	227M	235M	-16M	-65M	44M	48M	72M	220M
Other Long-Term Assets	10M	1.84B	112M	114M	159M	44M	48M	51M	61M
Receivables	804.6M	3.77B	3.6B	2.99B	2.56B	3.11B	2.88B	2.55B	2.68B
Inventory	720.6M	3.63B	3.8B	2.99B	2.36B	2.61B	2.82B	2.59B	2.49B
Other Current Assets	70.2M	947M	618M	880M	814M	619M	407M	365M	413M
Total Current Assets	1.88B	9.46B	9.24B	7.82B	6.91B	7.05B	6.83B	6.14B	6.39B
Property-Plant & Equipment	2.97B	12.32B	12.07B	10.19B	9.61B	10.21B	9.7B	8.93B	8.64B
Goodwill & Intangibles	10.02B	4.53B	4.7B	5.02B	2.55B	1.93B	2.13B	2.43B	2.74B
Total Long-Term Assets	13.32B	18.93B	18.74B	16.94B	13.6B	13.39B	12.86B	12.24B	12.27B
Total Assets	15.2B	28.39B	27.98B	24.77B	20.51B	20.44B	19.7B	18.37B	18.66B
Account Payables	423.1M	1.62B	1.87B	1.49B	1.1B	1.12B	1.42B	1.34B	1.19B
Deferred Revenue	n/a	n/a	138M	163M	89M	664M	188M	205M	248M
Short-Term Debt	266.4M	3.04B	2.92B	1.98B	1.11B	1.38B	1.79B	971M	89M
Other Current Liabilities	337.9M	1.65B	1.36B	3.21B	1.15B	663M	2.13B	1.36B	1.29B
Total Current Liabilities	1.09B	7.26B	6.96B	5.67B	4.16B	4.74B	5.53B	4.58B	3.56B
Long-Term Debt	1.53B	4.33B	3.62B	n/a	3.24B	2.71B	1.47B	1.3B	1.71B
Other Long-Term Liabilities	39.7M	2.42B	2.88B	6.53B	1.36B	1.06B	1.26B	1.23B	1.64B
Total Long-Term Liabilities	2.93B	6.78B	6.79B	6.89B	5.11B	4.22B	2.73B	2.53B	3.35B
Total Liabilities	4.02B	14.04B	13.76B	12.56B	9.27B	8.96B	8.26B	7.11B	6.91B
Total Debt	1.8B	7.73B	411M	482M	3.78B	4.7B	3.26B	2.27B	1.8B
Common Stock	125.6M	75.49M	562M	564M	570M	582M	594M	610M	620M
Retained Earnings	11.03B	13.76B	13.06B	11.3B	11.26B	10.81B	10.94B	10.86B	10.48B
Comprehensive Income	n/a	-339M	213M	-40M	-600M	76M	-112M	-217M	629M
Shareholders Equity	11.18B	13.98B	13.84B	11.83B	11.23B	11.47B	11.43B	11.25B	11.73B
Total Investments	42.7M	267M	315M	59M	54M	59M	62M	88M	224M